An Algorithm as a Biomarker for Response to Immune Checkpoint Inhibitor Therapy

被引：1
|
作者：
Rimm, David L. [1 ]
机构：
[1] Yale Univ, Dept Pathol & Med Oncol, Sch Med, New Haven, CT USA
来源：
JAMA ONCOLOGY | 2023年 / 9卷 / 01期
关键词：
D O I：
10.1001/jamaoncol.2022.4772
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：60 / 61
页数：2
相关论文
共 50 条
  • [11] DNA Checkpoint Gene Mutation as a Biomarker for Immune Checkpoint Inhibitor Therapy in Advanced Biliary Tract Cancer
    Shin, Ji Eun
    Kim, Seung Tae
    ANTICANCER RESEARCH, 2024, 44 (05) : 2103 - 2108
  • [12] The role of the gut microbiome in regulating the response to immune checkpoint inhibitor therapy
    Dean, Nathan J.
    d'Arienzo, Paolo D.
    Ibraheim, Hajir
    Lee, Karla A.
    Olsson-Brown, Anna C.
    Pinato, David J.
    Powell, Nicholas
    BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2024, 72
  • [13] Rate of response to immune checkpoint inhibitor therapy in patients with conjunctival melanoma
    Esmaeli, Bita
    Ogden, Tyler
    Nichols, Matthew
    Lu, Tracy
    Debnam, J. Matthew
    Dimitriou, Florentia
    Mcquade, Jennifer
    Oliva, Isabella C. Glitza
    MELANOMA RESEARCH, 2025, 35 (02) : 130 - 144
  • [14] Response to a combination of erlotinib and bevacizumab therapy after immune checkpoint inhibitor
    Okauchi, Shinichiro
    Miyazaki, Kunihiko
    Yamada, Hideyasu
    Satoh, Hiroaki
    CLINICAL RESPIRATORY JOURNAL, 2020, 14 (05): : 500 - 501
  • [15] DNA damage and repair gene panel as a biomarker of immune checkpoint inhibitor response.
    Chen, Ming Huang
    Pan, Yi-Ru
    Wu, Chiao-En
    Yeh, Yi Chen
    Hung, Yi-Ping
    Chao, Yee
    Wang, Yu-Chao
    Lin, Chien-Hsing
    Hsieh, Jason Chia-Hsun
    Yeh, Chun-Nan
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [16] Sarcomas: Immune biomarker expression and checkpoint inhibitor trials
    Zhu, Mayanne M. T.
    Shenasa, Elahe
    Nielsen, Torsten O.
    CANCER TREATMENT REVIEWS, 2020, 91
  • [17] Mutation burden as a biomarker of response to immune checkpoint therapy in nine solid cancers
    Ganesan, Shridar
    Bhanot, Gyan
    Mehnert, Janice M.
    Silk, Ann W.
    Ross, Jeffrey S.
    Pavlick, Dean
    Ali, Siraj Mahamed
    Markowski, Paul
    Kaufman, Howard L.
    Sullivan, Ryan J.
    Lovly, Christine Marie
    Sosman, Jeffrey Alan
    Johnson, Douglas Buckner
    Betigeri, Anil
    Subramanian, Kalyanasundaram
    Panda, Anshuman
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (07)
  • [18] Immune thrombocytopenia after immune checkpoint inhibitor therapy
    Amanam, Idoroenyi
    Gupta, Rohan
    Pullarkat, Vinod
    Mei, Matthew
    BRITISH JOURNAL OF HAEMATOLOGY, 2021, 193 (03) : 677 - 681
  • [19] ER expression as a predictive biomarker for Immune Checkpoint Inhibitor Therapy in ER positive breast cancer
    Arima, Jun
    Taniguchi, Kohei
    Inomata, Yosuke
    Hagihara, Seita
    Suzuki, Shigenori
    Lee, Sangwoong
    CANCER SCIENCE, 2025, 116 : 1149 - 1149
  • [20] Retrospective analysis of digital biomarker predictability of immune checkpoint inhibitor therapy outcomes in patients with NSCLC
    Abousaud, Marin
    Frame, David
    Harvey, R. Donald
    Kaddoura, Layan
    Ekpenyong, Asari
    Abousaud, Aseala
    Steuer, Conor Ernst
    Derstine, Brian
    Wang, Nicholas C.
    Mackler, Emily R.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
12345